Parodontitis

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

AM-Pharma
AM-PharmaNetherlands - Utrecht
1 program
PARodontitis And Type 2 DIabetes in Elderly SubjectsN/A1 trial
Active Trials
NCT07135076CompletedEst. Dec 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AM-PharmaPARodontitis And Type 2 DIabetes in Elderly Subjects

Clinical Trials (1)

NCT07135076AM-PharmaPARodontitis And Type 2 DIabetes in Elderly Subjects

PARodontitis And Type 2 DIabetes in Elderly Subjects

Start: Jul 2017Est. completion: Dec 2019
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space